Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors

Overview of attention for article published in Journal of Translational Medicine, March 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Dimensions has found 71 publications that cite this research output.

Article in International Immunopharmacology (July 2023)

Article in Molecular Cancer (July 2023)

Article in Frontiers in Oncology (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.